Julie Wolfgram in Annandale, Minnesota

Medical School: Sorry, her university is not listed
Graduation Year: 2013
The Primary Medical Specialty for Julie Wolfgram is listed as: Nurse Practitioner
Approximate Years of Experience: 11
PAC (PECOS ID)#: 4688809536
NPI #: 1437583986
NPI Created On: 09/02/2013
NPI Last Updated Listed as: 03/11/2021
Primary Taxonomy Code: 363LF0000X
License Number:
R157686-3
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Medica Health Plans of Wisconsin
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Blood test, basic group of blood chemicals
3. Blood test, lipids (cholesterol and triglycerides)
4. Hemoglobin a1c level
5. Blood test, thyroid stimulating hormone (tsh)
6. Vaccine for influenza for administration into muscle, 0.5 ml dosage
7. Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Established patient office or other outpatient, visit typically 40 minutes
12. Physician telephone patient service, 5-10 minutes of medical discussion
13. Physician telephone patient service, 11-20 minutes of medical discussion
14. Physician telephone patient service, 21-30 minutes of medical discussion
15. Administration of influenza virus vaccine
16. Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous
17. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
18. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
19. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r